An experience of application of telmisartan (micardis) in therapy of patients with diabetes mellitus type 2, diabetic nephropathya and arterial hypertension
Journal: I.P. Pavlov Russian Medical Biological Herald (Vol.8, No. 4)Publication Date: 2007-12-20
Authors : Filatova T.E.; Pchelincev V.P.; Davidov V.V.; Borosdin A.V.;
Page : 113-116
Keywords : ;
Abstract
Evaluating the results of a 3-munth therapy undertaken by Filatova T.E., Pchelincev V.P., Davidov V.V., Borosdin A.V. shows that the application of antagonist of angiotensin II receptor telmisartan (micardis) in the treatment of patients with diabetes mellitus type 2, diabetic nephropathya and arterial hypertension guarantees especially strong and true anti-hypertension and anti-proteinuric effects.
Other Latest Articles
- The improvement of psychiatric service structure as the most important factor in increasing the level of public health
- The significance of the additional examination techniques in modern herniology
- Functional morphology of adrenal gland in acute myocardial infarction
- Optimization of management of the pregnant infected with Ureaplasma urealyticum
- Variability of cardiac rhythm as criterion of optimal effect of local physiotherapeutic actions
Last modified: 2016-03-05 04:02:12